It has been reported that reduction of RIPK3 in CRC cells induces expansion of MDSCs and increases cyclooxygenase-2 (COX-2) expression, which then catalyze PGE2 and enhance MDSCs function (96). The gene discussed is RIPK3; the disease is colorectal carcinoma.